Glucosamine Sulfate vs HCl: None of 900 Labels Names the Trial Form

The standard advice on glucosamine fits in one line: buy sulfate, not hydrochloride. It has a real basis. The positive trials used glucosamine sulfate, and the largest US trial, which used hydrochloride, found nothing. But when you read the trials closely, the line that divides the positive results from the negative ones is not sulfate versus hydrochloride. It is one particular product versus everything else.

We read the trials and counted what US labels actually say.

What the positive trials used

Two three-year trials put glucosamine on the map. In the first, 212 people with knee osteoarthritis took 1,500 mg of glucosamine sulphate or placebo once daily for 3 years. Joint space narrowed by 0.31 mm on placebo and by 0.06 mm on glucosamine. The second reported narrowing of 0.19 mm on placebo against essentially none (0.04 mm) with glucosamine sulfate.

Both used the same preparation, which the Cochrane review lists among its Rotta trials: a patented crystalline glucosamine sulfate originally from the Rotta company, now marketed by Mylan. A 2019 review co-authored by the lead investigator of the first trial puts it plainly: evidence is “greatest for the patented crystalline glucosamine sulfate (pCGS) formulation”, given “as a highly bioavailable once-daily dose (1500 mg)”.

What the Cochrane review found when it split the trials

The 2005 Cochrane review pooled 20 trials and then did something most shopping advice skips: it separated them by preparation.

Trials	Pain result versus placebo
10 trials of the Rotta preparation	Favoured glucosamine (SMD -1.31)
Trials of other glucosamine preparations	Not significant (SMD -0.15)
8 trials with adequate allocation concealment	”Failed to show benefit” for pain and function

So the benefit sat with one product, and it shrank when the review looked only at the better-concealed trials.

The independent trials, sulfate and hydrochloride

If sulfate itself were the answer, an independent trial of glucosamine sulfate at the trial dose should have found it. The Australian LEGS trial did exactly that test. It gave 605 people with knee pain glucosamine sulfate 1,500 mg once daily, chondroitin, both, or placebo for 2 years. Every group, placebo included, reported less knee pain over the first year, and “none of the treatment allocation groups demonstrated significant symptomatic benefit above placebo.” The combination group showed 0.10 mm less joint space narrowing; glucosamine sulfate alone did not.

GAIT, the US trial, used glucosamine hydrochloride, 500 mg three times daily, in 1,583 people for 24 weeks. The response rate to glucosamine was 3.9 percentage points above placebo, which was not significant (P=0.30).

A 2010 network meta-analysis of 10 trials and 3,803 patients drew the pattern together: “Industry independent trials showed smaller effects than commercially funded trials.”

What 900 US sulfate labels say

On 14 October 2026 we counted every on-market label with a glucosamine ingredient that the NIH Dietary Supplement Label Database returned across five searches. The plain search reports 13,882 results and the database’s API returns only the first 10,000, so we added searches for each form; the counts below are what those searches returned, not a guaranteed census.

Glucosamine form named on the label	Labels
Sulfate only	900
Hydrochloride (HCl) only	738
N-acetyl glucosamine only	109
More than one form	78
Form not stated	71
Total	1,896

Then we looked at what the 900 sulfate labels say about the sulfate:

• 432 name potassium, as glucosamine sulfate potassium chloride or “2KCl”.
• 1 names sodium chloride.
• 467 name no stabiliser at all.
• 0 describe their glucosamine as crystalline.

Regular glucosamine sulfate is “stabilized with potassium or sodium chloride”, in the words of a 2025 study. Does the crystalline form make a difference once it is in your stomach? That 2025 pilot study tried to find out. It gave 10 healthy adults a single 1,500 mg dose of each and found “no significant pharmacokinetic advantage” for the crystalline form, while warning that “the small sample size” limits what it shows. So the evidence that the crystalline form is absorbed differently is thin in both directions. What is clear is that the US label does not tell you which one you are buying, and the independent trial of ordinary glucosamine sulfate at 1,500 mg did not beat placebo.

The National Center for Complementary and Integrative Health notes the regulatory split that sits behind this: in the US, glucosamine is sold “as either glucosamine sulfate or glucosamine hydrochloride” as a dietary supplement, while “in some other countries, certain preparations of glucosamine and chondroitin are sold as prescription drugs.”

How much the labels give

The trials gave 1,500 mg a day, once daily in the sulfate trials and as 500 mg three times a day in GAIT. We read 300 randomly chosen labels in full.

• 297 list a glucosamine row, and 42 of them give no glucosamine amount, usually because it sits inside a blend.
• Of 247 labels with serving directions, at the label’s maximum daily servings 108 come to exactly 1,500 mg, 62 to more and 77 to less. The median is 1,500 mg.
• 127 labels are once-daily, and 78 of those give 1,500 mg or more in that single serving.

So most labels can reach the trial amount, but roughly a third of the labels with directions do not, and one in seven of the sampled labels does not let you check.

What this means if you want to try glucosamine

• Sulfate versus HCl is not the decision that matters. The independent trials of both forms did not beat placebo for knee pain. The positive results belong to one patented crystalline product, and no US label we counted claims that form.
• If you try it anyway, pick a label that states the glucosamine amount and gives 1,500 mg a day, the dose every trial here used.
• Set an end date. The trials ran for months. Track your knee pain and stop if it has not clearly changed after about three months. In LEGS, the placebo group improved too, so improvement alone does not prove the supplement worked.
• Shellfish. Many labels list crab or shrimp as the source; check the label if you have a shellfish allergy.

For how glucosamine compares with omega-3, curcumin and the other joint options, see our ranking of supplements for joint pain.

We do not link to any product on this page. The trials that worked tested a product we cannot identify on a US label, and the independent trials of the forms you can buy did not show a benefit over placebo.

The bottom line

The advice to buy sulfate rather than hydrochloride rests on trials of one patented crystalline glucosamine sulfate. When a 2005 Cochrane review separated those 10 trials from the rest, the benefit stayed with them, and an independent 2-year trial of glucosamine sulfate 1,500 mg once daily found no pain benefit over placebo. Of 900 US labels selling glucosamine sulfate alone, none calls it crystalline. If you try glucosamine, choose a label that states 1,500 mg a day and give it a fixed trial, but do not expect the word “sulfate” on the bottle to carry the results of the trials.